INTUITIVE SURGICAL, INC.

(ISRG)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
206.10 USD   +2.69%
06/30Intuitive and Siemens Healthineers enhance scanning integration for Ion Endoluminal procedures
GL
06/30Intuitive and Siemens Healthineers enhance scanning integration for Ion Endoluminal procedures
AQ
06/30Intuitive and Siemens Healthineers Enhance Scanning Integration for Ion Endoluminal Procedures
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
207.94(c) 201.99(c) 202.59(c) 200.71(c) 206.1(c) Last
1 900 789 1 662 380 1 655 394 2 224 471 1 459 803 Volume
-0.83% -2.86% +0.30% -0.93% +2.69% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 6 385 M - -
Net income 2022 1 510 M - -
Net cash position 2022 2 701 M - -
P/E ratio 2022 51,0x
Yield 2022 -
Sales 2023 7 211 M - -
Net income 2023 1 755 M - -
Net cash position 2023 4 357 M - -
P/E ratio 2023 43,8x
Yield 2023 -
Capitalization 73 981 M 73 981 M -
EV / Sales 2022 11,2x
EV / Sales 2023 9,66x
Nbr of Employees 9 793
Free-Float 99,5%
More Financials
Company
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sales of instruments and accessories (54.3%): primarily wrist cuffs; - sales of robotic systems (29.7%): systems marketed under the da... 
More about the company
Ratings of Intuitive Surgical, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about INTUITIVE SURGICAL, INC.
06/30Intuitive and Siemens Healthineers enhance scanning integration for Ion Endoluminal pro..
GL
06/30Intuitive and Siemens Healthineers enhance scanning integration for Ion Endoluminal pro..
AQ
06/30Intuitive and Siemens Healthineers Enhance Scanning Integration for Ion Endoluminal Pro..
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell 1000 Dynamic Index
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell 1000 Value Index
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell 3000E Value Index
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell 3000 Value Index
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell Top 200 Value Index
CI
06/24INTUITIVE SURGICAL, INC.(NASDAQGS : ISRG) added to Russell 1000 Value-Defensive Index
CI
06/22Deutsche Bank Adjusts Price Target on Intuitive Surgical to $225 From $300, Maintains H..
MT
06/14TRANSCRIPT : Intuitive Surgical, Inc. Presents at Goldman Sachs 43rd Annual Global Healthc..
CI
06/07UBS Adjusts Intuitive Surgical Price Target to $320 From $325, Maintains Buy Rating
MT
05/23Creo Medical Signs Collaboration With Intuitive Surgical
DJ
05/23Creo Medical Group PLC Signs A Long-Term Multi-Year Collaboration Agreement with Intuit..
CI
05/17Citigroup Adjusts Intuitive Surgical's Price Target to $305 From $360, Reiterates Buy R..
MT
More news
News in other languages on INTUITIVE SURGICAL, INC.
06/30Intuitive et Siemens Healthineers améliorent l'intégration de la numérisation pour les ..
05/23Creo Medical Group PLC signe un accord de collaboration pluriannuel à long terme avec I..
04/28VENTE D'INITIÉS : Intuitive Surgical
04/22Wall Street cae por debilidad de los resultados de empresas y preocupación por las tasa..
04/22MÄRKTE USA/Abschläge - Anleger reduzieren Risiken vor dem Wochenende
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Stock Trading Strategies
INTUITIVE SURGICAL, INC. - 2021
The underlying trend is in force again
BUY
More Stock Trading Analysis
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 206,10 $
Average target price 313,58 $
Spread / Average Target 52,1%
EPS Revisions
Managers and Directors
Gary S. Guthart Chief Executive Officer & Director
Jamie E. Samath Chief Financial Officer & Senior Vice President
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Kara Andersen Reiter Assistant General Counsel
Sector and Competitors